Research
Home > Cancer (Oncology) > Research and Clinical Trials > Research
Print

Research and Clinical Trials

Research

Insights and Innovations: Nanomedicine

According to Steven K. Libutti, MD, Director of the Montefiore Einstein Center for Cancer Care, "Nanotechnology are really, in essence, small platforms to deliver cancer therapies directly to the cancer that can be more effective against the tumor, and less damaging or toxic to our patients." Learn more by viewing this new TV commercial, airing on NBC, which highlights the Montefiore Einstein Center for Cancer Care's work with nanotechnology in order to help advance cancer care. 


Exploring New Possibilities in Breast Cancer Care

June 27, 2011

A new experimental drug may enhance the effectiveness of certain chemotherapy drugs when treating advanced metastatic breast cancer, according to Eleni Andreopoulou, MD, a medical oncologist in the Breast Cancer Program of Montefiore Einstein Center for Cancer Care and principal investigator of a promising new clinical trial. Read more.


Nanomedicine Introduces New Treatment Options

November 30, 2010

Results from a recent clinical trial suggest a drug made using nanotechnology — the application of microscopic particles to help deliver therapeutics-showed a great deal of promise in treating advanced cancer. Read more.


$10.8 million NIH Grant Explores Stem Cell Regeneration
Following Radiation Exposure

November 30, 2010

Chandan Guha, MD, Vice Chairman and Professor of Radiation Oncology and Pathology at Montefiore and Albert Einstein College of Medicine, received a five-year, $10.8 million National Institutes of Health (NIH) grant to develop stem-cell based therapies to treat radiation-induced toxicity and death in patients. Read more.